Andrew Einhorn
Director of Finance/CFO chez Osmotica Pharmaceutical Corp.
Profil
Andrew J.
Einhorn is the founder of ESP Pharma, Inc. (founded in 2003), Esprit Pharma, Inc. (founded in 2005), and Oceana Therapeutics, Inc. (founded in 2008).
He held the titles of Chief Financial Officer & Senior Vice President at ESP Pharma, Inc., Chief Financial Officer & Executive Vice President at Esprit Pharma, Inc., and Chief Financial Officer & Executive VP at Oceana Therapeutics, Inc. Mr. Einhorn's current jobs include Chief Financial Officer at Osmotica Pharmaceutical Corp.
(since 2017) and Venture Advisor at Israel Biotech Fund (since 2015).
Mr. Einhorn's former jobs include Managing Director at The PNC Financial Services Group, Inc., Managing Director at Credit Lyonnais, Chief Financial Officer at MYOS RENS Technology, Inc., Chief Financial Officer at Edge Therapeutics, Inc., Vice President at Chase Securities, Inc., Vice President at BT Securities Co., Ltd., and Chief Financial & Accounting Officer at RVL Pharmaceuticals Plc.
He also held the title of Chief Accounting Officer at Cognition Therapeutics, Inc. in 2023.
Mr. Einhorn's education includes an undergraduate degree from American University, a graduate degree from Northwestern University, and an undergraduate degree from Middlebury College.
Postes actifs de Andrew Einhorn
| Sociétés | Poste | Début |
|---|---|---|
Osmotica Pharmaceutical Corp.
 Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Director of Finance/CFO | 01/09/2017 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | 01/01/2015 |
Anciens postes connus de Andrew Einhorn
| Sociétés | Poste | Fin |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Director of Finance/CFO | 01/05/2023 |
| RVL PHARMACEUTICALS PLC | Director of Finance/CFO | 18/04/2022 |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Director of Finance/CFO | 10/03/2017 |
| MEDAVAIL HOLDINGS, INC. | Director of Finance/CFO | 06/02/2013 |
Oceana Therapeutics, Inc.
 Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Founder | 01/01/2012 |
Formation de Andrew Einhorn
| American University | Undergraduate Degree |
| Northwestern University | Graduate Degree |
| Middlebury College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PNC FINANCIAL SERVICES GROUP, INC. | Finance |
| COGNITION THERAPEUTICS, INC. | Health Technology |
| RVL PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 10 |
|---|---|
ESP Pharma, Inc.
 ESP Pharma, Inc. Pharmaceuticals: MajorHealth Technology ESP Pharma, Inc. produces pharmaceutical products. The company used to produce drug for acute-care hospital use and these drugs include therapeutics for high blood pressure and angina; one product, IV Busulfex, is used to prepare myelogenous for leukemia patients for bone marrow transplants. The company formulates its products to be delivered intravenously or by injection when oral administration is impossible. The company was founded in April, 2002 and was headquartered in Edison, NJ | Health Technology |
Esprit Pharma, Inc.
 Esprit Pharma, Inc. Pharmaceuticals: MajorHealth Technology Esprit Pharma, Inc. manufactures and supplies pharmaceutical products. The company offers SANCTURA, a treatment for over-active bladder and PRO-QUIN, a treatment for urinary tract infections. The company was founded in 2005 and is headquartered in East Brunswick, NJ. | Health Technology |
MYOS RENS Technology, Inc.
 MYOS RENS Technology, Inc. Medical SpecialtiesHealth Technology MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ. | Health Technology |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
| Chase Securities, Inc. | Finance |
| BT Securities Co., Ltd. | Finance |
Osmotica Pharmaceutical Corp.
Osmotica Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Osmotica Pharmaceutical Corp. provides drug delivery technologies and neurology based therapies. It develops and commercializes a portfolio of products related to central nervous system disorders with a focus in Parkinson's disease and related neurological disorders. The company was founded in 1986 and is headquartered in Bridgewater, GA. | Health Technology |
Oceana Therapeutics, Inc.
Oceana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oceana Therapeutics, Inc. manufactures pharmaceuticals and medical devices. It develops and commercializes therapeutics with a focus on colorectal, gastroenterology, and urological diseases. The firm provides Deflux that is used for the treatment of Vesicoureteral reflux, urological conditions and Solesta which is used for the treatment of fecal incontinence. The company was founded in 2008 and is headquartered in Edison, NJ. | Health Technology |
Credit Lyonnais
 Credit Lyonnais Major BanksFinance Part of Rue la Boétie SAS, Credit Lyonnais provides commercial banking services. The private company is based in Frankfurt am Main, Germany. | Finance |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
